Pagan Douglas W. 4
4 · Dicerna Pharmaceuticals Inc · Filed Dec 17, 2021
Insider Transaction Report
Form 4
Pagan Douglas W.
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2021-12-15$38.05/sh−602$22,906→ 7,775 total - Exercise/Conversion
Common Stock
2021-12-15+2,050→ 8,377 total - Exercise/Conversion
Restricted Stock Units
2021-12-15−2,050→ 6,150 total→ Common Stock (2,050 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's Common Stock.
- [F2]Includes shares acquired under the DRNA 2014 Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c).
- [F3]Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
- [F4]The RSUs vest over a period of four years, with 25% of the RSUs vesting on each of the first, second, third and fourth anniversaries of December 15, 2020, subject in each case to the Reporting Person's continued employment or service with the Issuer through the applicable vesting date.